Clinical Trials
3 trialsNCT00456495 2017-07-21
Effect of Ranibizumab on Malignant Conjunctival Neoplasia
The New York Eye Cancer Center
Phase 1 Completed
NCT00680225 2017-04-12
Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma
New England Retina Associates
Phase 3 Completed
NCT01251978 2016-10-19
Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma (Cohort 2)
New England Retina Associates
Phase 2 Completed